Task force's role in reform bills draws scrutiny in the wake of mammography guidelines

The Washington Post reports that the "once-obscure federal panel that triggered a firestorm with its new mammography guidelines would get far greater authority under the health-care reform proposals pending in Congress, sparking more debate about its power and independence. Critics of the U.S. Preventive Services Task Force say that the panel would become a stealth tool for government bureaucrats bent on rationing health care. Supporters worry that little-noticed provisions to overhaul the group would jeopardize its long-valued objectivity." The task force has been "the federal government's primary source of recommendations for doctors and patients" since it was created in 1984. It provides expert guidance "on how to try to prevent health problems. Although its guidelines have long been considered authoritative and have been used to determine some Medicare coverage, the group's conclusions have been primarily advisory." But in the health bills pending in both the Senate and House, "the panel's ratings would serve as the basis for determining which preventive services the government would require insurance plans to cover at little or no cost to patients" (Stein, 12/20).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
A Discussion with Hologic’s Tim Simpson on the Future of Cervical Cancer Screening